- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Aurobindo Pharma MD N Govindarajan steps down
![Aurobindo Pharma MD N Govindarajan steps down Aurobindo Pharma MD N Govindarajan steps down](https://medicaldialogues.in/h-upload/2020/09/04/750x450_133988-aurobindo.webp)
New Delhi: Drug firm Aurobindo Pharma on Friday said N Govindarajan has tendered his resignation as the managing director and a director on the company's board due to personal reasons.
"His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the services of the company effective from the close of business on December 31, 2021," Aurobindo Pharma said in a regulatory filing.
Also Read:Aurobindo Pharma arm submits first biosimilar filing with EMA
"The board has further taken note of the appointment of P Yugandhar as the chief executive officer of Eugia Pharma Specialities Ltd, a wholly-owned subsidiary of the company focused on generic injectables and oncology business," Aurobindo Pharma said.
Also Read:Five firms including Cadila, Aurobindo Pharma in race to buy bankrupt Sterling Biotech